We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

WERFEN

Werfen provides diagnostic instruments for critical care and hemostasis to meet the testing needs of medical professi... read more Featured Products: More products

Download Mobile App





Werfen Showcases Latest Innovations in Specialized Diagnostics

By LabMedica International staff writers
Posted on 22 May 2023
Print article
Image: The GEM Premier 5000 whole-blood, blood gas testing system (Photo courtesy of Werfen)
Image: The GEM Premier 5000 whole-blood, blood gas testing system (Photo courtesy of Werfen)

Werfen (Barcelona, Spain) is participating in the 2023 WordLab-EuroMedLab Congress, the leading event in the field of laboratory medicine and clinical chemistry that brings together top experts and scientists from around the world. As a silver sponsor of the Congress, Werfen is welcoming visitors at La Nuvola Convention Center in Rome to its futuristic 80 square meters booth, ready to present its innovations in specialized diagnostics through its products and solutions.

Werfen provides advanced in vitro diagnostic solutions, catering to both point-of-care and lab testing needs. Its acute care diagnostic solutions address healthcare challenges across various healthcare settings, including cardiovascular operating rooms, catheterization labs, intensive care units, and emergency departments, improving efficiency and enhance patient care. At EuroMedLab Rome 2023, Werfen is highlighting its comprehensive and integrated line of acute care diagnostics. This includes the company’s blood gas family, featuring the GEM Premier and Avoximeter product lines, as well as the whole blood hemostasis family, featuring the ROTEM, Hemochron, and VerifyNow product lines.

As an active player in scientific knowledge, Werfen is promoting two educational sessions that will take place during the event. The first session titled 'Leveraging Innovative Technology to Optimize Quality in Point-of-Care Blood Gas Testing' will start by offering insights into the sources of preanalytical errors in point-of-care testing, followed by identification of the benefits of automated, continuous quality assurance vs. intermittent liquid quality control (QC). The speakers will identify strategies to address the risks of variability in sample collection, for enhanced patient safety and review the history of QC and novel Patient-Based, Real-Time QC. The session will conclude with a review of strategies to achieve higher quality standards with proactive tracking and monitoring of KPIs, using data management solutions.

The second session titled 'The value of experience in coagulation and autoimmunity. Werfen, Powering Patient Care' will focus on the value that automation and dedicated data management solutions, combined with the company's high specialization, can offer to laboratorians and clinicians, in Hemostasis and Autoimmunity, to ensure the best levels of patient care. In addition, the speaker will explain the organizational advantages of shortened turnaround time while increasing laboratory efficiency.

Werfen is also sponsoring the Satellite Meeting “Point-of-Care Testing: Home, Hospital and Beyond” - a forum for companies and industry experts to discuss topics around innovations and the future of POCT. In his talk “POC Organizational Models in the World and IT Solutions”, Davide Colombo, Global Acute Care Expert at Werfen, will share hospital organizational models and POC technology know-how in different countries, as well as explain the industry's role in the success of these organizations.

Related Links:
Werfen

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.